Torren Management’s Amicus Therapeutics FOLD Stock Holding History

Torren Management’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-80	Closed	-$1.16K	–	961
2026 Q1	$1.16K	Sell	80 -94	-54%	-$1.35K	﹤0.01%	701
2025 Q4	$2.48K	Buy	+174	New	+$1.71K	﹤0.01%	1027

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Torren Management's FOLD Position: Q2 2026 in Review

Torren Management sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 80 shares — an estimated $1.16K sold.

Torren Management first reported a position in FOLD in Q4 2025 and held it in 2 quarters. The position peaked at $2.48K in Q4 2025. 1 fund tracked by Wall St. Rank holds FOLD as of Q2 2026.

Torren Management reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
Torren Management sold 80 Amicus Therapeutics shares in Q2 2026, an estimated $1.16K.
Torren Management first reported a position in Amicus Therapeutics in Q4 2025 and held it in 2 quarters.
Torren Management's Amicus Therapeutics position peaked at $2.48K in Q4 2025.
1 fund tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Torren Management's 13F filing for Q2 2026, filed 10 Jul 2026.